For the year ending 2025-12-31, MYGN made $824,500K in revenue. -$365,900K in net income. Net profit margin of -44.38%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 824,500 | 837,600 | ||
| Cost of revenue | 247,900 | 252,200 | ||
| Gross profit | 576,600 | 585,400 | ||
| Research and development expense | 106,800 | 113,400 | ||
| Sales and marketing expense | 280,800 | 284,100 | ||
| General and administrative expense | 256,800 | 275,900 | ||
| Legal settlements | 0 | -21,300 | ||
| Goodwill and long-lived asset impairment charges | 319,400 | 56,800 | ||
| Total operating expenses | 963,800 | 708,900 | ||
| Operating loss | -387,200 | -123,500 | ||
| Interest income | 1,800 | 1,700 | ||
| Interest expense | 10,500 | 2,800 | ||
| Other | 800 | 1,100 | ||
| Total other expense | -7,900 | 0 | ||
| Loss before income tax | -395,100 | -123,500 | ||
| Income tax (benefit) expense | -29,200 | 3,800 | ||
| Net loss | -365,900 | -127,300 | ||
| Basic EPS | -3.95 | -1.41 | ||
| Diluted EPS | -3.95 | -1.41 | ||
| Basic Average Shares | 92,600,000 | 90,600,000 | ||
| Diluted Average Shares | 92,600,000 | 90,600,000 | ||
MYRIAD GENETICS INC (MYGN)
MYRIAD GENETICS INC (MYGN)